Inhouse product
Indications
Itrakill SB is used for the treatment of
oropharyngeal candidiasis, vulvovaginal candidiasis, pityriasis versicolor,
tinea pedis, tinea cruris, tinea corporis, tinea manuum, onychomycosis,
histoplasmosis. It is indicated in the treatment of systemic candidiasis,
aspergillosis, and cryptococcosis (including cryptococcal meningitis). It is
also used for maintenance therapy in AIDS patients to prevent relapse of
underlying fungal infections and in the prevention of fungal infection during
prolonged neutropenia.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Pharmacology
Itraconazole inhibits Cytochrome P-450 dependent enzymes
resulting in impairment of the biosynthesis of ergosterol, a major component of
the cell membrane of yeast and fungal cells. Being integral to the proper
functioning of the cell membrane, inhibition of the synthesis of ergosterol
leads to a cascade of abnormalities in permeability, membrane bound enzyme
activity, and co-ordination of chitin synthesis leading to inhibition of
growth, abnormal cell wall formation and accumulation of intracellular lipids
and membranous vesicles.
SUBA (Super Bio-available) technology is a novel technology for enhancing the
bioavailability of poorly soluble drugs. This technology utilizes a solid
dispersion of drug in a polymer that improves the dissolution of poorly soluble
drugs compared to their normal crystalline form. SUBA technology Itraconazole
is an orally active triazole antifungal drug that has demonstrated a broad
spectrum of activity and favorable pharmacokinetic profile.
Dosage & Administration
100 & 200 mg preparation:
For non-systemic fungal disease
For
systemic fungal disease-
Aspergillosis: 200 mg once daily for 2-5 months Increase
dose to 200 mg twice daily in case of invasive or disseminated disease
The dose and duration of treatment for systemic antifungal
disease should be adjusted depending on the clinical response.
65
mg & 130 mg preparation:
For non-systemic fungal
disease-
Vulvovaginal
candidiasis: 130 mg twice daily for 1 day
For
systemic fungal disease-
Aspergillosis: 65 mg twice daily for 2-5 months.Increase
dose to 130 mg twice daily in case of invasive or disseminated disease
The
dose and duration of treatment for systemic anti-fungal disease should be
adjusted depending on the clinical response.
pediatric
use: The efficacy and safety of the Itraconazole capsule have not been
established in pediatric patients.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Interaction
The drugs like terfenadine, astemizole, cisapride, HMG-CoA
reductase inhibitors such as simvastatin, oral midazolam or triazolam should
not be given concurrently with Itrakill SB. Significant interactions also
observed during co-administration of rifampin, phenytoin, phenobarbital,
digoxin, and calcium channel blockers. There is no experience of overdosage
with Itrakill SB.
Contraindications
Itraconazole is contraindicated in patients with known
hypersensitivity to the drug or any ingredient in the formulation. Patients who
have severe hepatic disease are not advised to take Itraconazole. It is not
advisable to use the drug in patients taking rifampin, which appears to
initially inhibit and then enhance the metabolism of Itraconazole.
Side Effects
Nausea, abdominal pain, dyspepsia, constipation, headache,
dizziness, raised liver enzymes, menstrual disorders, allergic reactions
(including pruritus, rash, urticaria and angioedema), hepatitis and cholestatic
jaundice, peripheral neuropathy and Stevens-Johnson syndrome reported. On
prolonged use hypokalaemia, oedema and hair loss reported.
Pregnancy & Lactation
Itraconazole
is contraindicated in pregnancy. Breast feeding while receiving Itraconazole is
not recommended.
Precautions & Warnings
Absorption is impaired when gastric acidity is reduced. In
patients receiving acid neutralizing medicines (e.g. aluminium hydroxide),
these should be administered at least 2 hours after the intake of Itrakill SB.
The drug should be administered after a full meal. Rarely, cases of hepatitis
and jaundice have been reported mainly in patients treated for longer than one
month. It is therefore, advised to monitor liver function in patients receiving
continuous treatment of more than one month.
Therapeutic Class
Drugs
for subcutaneous and mycoses
Storage Conditions
Store
below 25°C, in a cool & dry place. Keep away from light. Keep all the
medicine out of the reach of children.
Common Questions about
Itrakill SB 65 mg Capsule
What is Itrakill SB 65 mg Capsule?
Itrakill
SB 65 mg Capsule is an antifungal medication that inhibits Cytochrome P-450
dependent enzymes.
What is Itrakill SB 65 mg Capsule used for?
Itrakill
SB 65 mg Capsule is used to treat fungal infections.
How long is the duration of effect?
The effect of Itrakill
SB 65 mg Capsule lasts up to 16 to 28 hours.
What is the onset of action?
The peak effect of
Itrakill SB 65 mg Capsule is observed to be in 2 hours.
Are there any pregnancy warnings?
Itrakill
SB 65 mg Capsule is not recommended to pregnant women. In the case of absolute
necessity, one must consult the doctor and discuss its pros and cons.
Is it habit forming?
Itrakill SB 65 mg
Capsule is not reported to be a habit forming drug.
Are there any breast-feeding warnings?
Itrakill SB 65 mg
Capsule is not recommended for breastfeeding women. In the case of absolute
necessity, one must consult the doctor and discuss its pros and cons.
Quick Tips
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Login Or Registerto submit your questions to seller
No none asked to seller yet